Unison Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.89M Buy
7,465
+35
+0.5% +$13K 0.2% 59
2026
Q1
$2.18M Buy
7,430
+32
+0.4% +$10.5K 0.17% 67
2025
Q4
$2.59M Buy
7,398
+35
+0.5% +$11.8K 0.23% 54
2025
Q3
$2.38M Buy
7,363
+35
+0.5% +$10.9K 0.22% 61
2025
Q2
$2.85M Buy
7,328
+28
+0.4% +$11.3K 0.32% 46
2025
Q1
$3.18M Buy
+7,300
New +$2.93M 0.4% 42

Other funds holding ELV

Unison Advisors's ELV Position: Q2 2026 in Review

Unison Advisors increased its Elevance Health (ELV) stake by 0.47% in Q2 2026, buying an estimated $13K and bringing the position to 7,465 shares worth $2.89M. The position accounts for 0.2% of the portfolio, ranked #59.

Unison Advisors first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.18M in Q1 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Unison Advisors held 7,465 shares of Elevance Health worth $2.89M as of Q2 2026.
  • Unison Advisors bought 35 Elevance Health shares in Q2 2026, an estimated $13K.
  • Elevance Health made up 0.2% of Unison Advisors's portfolio in Q2 2026, its #59 holding.
  • Unison Advisors first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • Unison Advisors's Elevance Health position peaked at $3.18M in Q1 2025.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Unison Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.